Terray Therapeutics
Terray Therapeutics Unveils EMMI: AI-Driven Platform Revolutionizes Small Molecule Drug Discovery
Terray Therapeutics; EMMI; generative AI; small molecule drug discovery; AI-native platform; chemical space; drug optimization; biotech; machine learning; COATI model
Terray Therapeutics and Gilead Sciences Collaborate on AI-Driven Drug Discovery to Accelerate Small Molecule Therapies
AI-driven drug discovery, Terray Therapeutics, Gilead Sciences, Small molecule therapies, tNova platform, High-throughput experimentation, Generative AI, Strategic collaboration
Terray Therapeutics Secures $120M Series B Funding to Advance AI-Driven Small Molecule Drug Development
AI-driven drug discovery, small molecule development, Terray Therapeutics, series B funding, biotechnology, pharmaceutical innovation.